Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04880382
What this trial is testing

Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Institut Bergonié 8
Early research (Phase 1)Study completedNCT02300259
What this trial is testing

LY2623091 in Healthy Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 48
Not applicableUnknownNCT03546010
What this trial is testing

Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition

Who this might be right for
Attention Deficit-Hyperactivity
University Hospital, Grenoble 60
Not applicableStudy completedNCT00017979
What this trial is testing

Study of Brain Control of Movement

Who this might be right for
Movement DisorderHealthy
National Institute of Neurological Disorders and Stroke (NINDS) 30
Post-approval studies (Phase 4)UnknownNCT01835613
What this trial is testing

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

Who this might be right for
Rheumatoid Arthritis (RA)
Osservatorio Epidemiologico GISEA 150
Early research (Phase 1)Study completedNCT02299518
What this trial is testing

Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Alice Mims 23
Not applicableStudy completedNCT04837417
What this trial is testing

Deficit in Quadriceps Voluntary Activation After Anterior Cruciate Ligament Reconstruction: Roles of the "Learned Non-use" Paradigm and the Interhemispheric Inhibition

Who this might be right for
Anterior Cruciate Ligament Injuries
Istituto Auxologico Italiano 10
Testing effectiveness (Phase 2)Looking for participantsNCT06735820
What this trial is testing

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

Who this might be right for
Malignant Peripheral Nerve Sheath Tumor (MPNST)Neurofibromatosis 1 (NF1)Atypical Neurofibroma
AeRang Kim 45
Early research (Phase 1)Study completedNCT02544880
What this trial is testing

PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
Donald T. Weed, MD, FACS 16
Not applicableNot Yet RecruitingNCT07832669
What this trial is testing

Stimulation of Peripheral Afferents to Reduce Muscle Inhibition at the Knee

Who this might be right for
Knee OsteoarthristisKnee Pain ArthritisKnee Pain Chronic
Northeastern University 50
Not applicableStudy completedNCT00302913
What this trial is testing

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Who this might be right for
Coronary Artery DiseaseDrug Resistance
University Heart Center Freiburg - Bad Krozingen 120
Early research (Phase 1)Study completedNCT02201303
What this trial is testing

Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 40
Not applicableUnknownNCT02239458
What this trial is testing

DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Ram Weiss 60
Not applicableStudy completedNCT00683774
What this trial is testing

Insulin and Polycystic Ovary Syndrome

Who this might be right for
PCOS
Virginia Commonwealth University 21
Not applicableStudy completedNCT00636090
What this trial is testing

Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001

Who this might be right for
Metastatic Hormone Refractory Prostate Cancer
Duke University 35
Not applicableStudy completedNCT02329587
What this trial is testing

Transcranial Direct Current Stimulation Augmented Exposure and Response Prevention for Obsessive-Compulsive Disorder

Who this might be right for
Obsessive-Compulsive Disorder
Butler Hospital 13
Post-approval studies (Phase 4)UnknownNCT04722640
What this trial is testing

Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity

Who this might be right for
Psoriasis
Istituto Clinico Humanitas 240
Testing effectiveness (Phase 2)Looking for participantsNCT06918132
What this trial is testing

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more
Mayo Clinic 60
Large-scale testing (Phase 3)Study completedNCT00996606
What this trial is testing

Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00001698
What this trial is testing

Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

Who this might be right for
LeukoplakiaPeriodontal Disease
National Cancer Institute (NCI) 57
Next Page